| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |